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Apart from their canonical role in ribosome biogenesis, there is increasing evidence of ribosomal protein genes’ involvement in
various cancers. A previous study by us revealed significant differential expression of three ribosomal protein genes (RPeL27,
RPeL41, and RPeL43) between cell lines derived from tumor and normal nasopharyngeal epithelium. However, the results therein
were based on a semiquantitative assay, thus preliminary in nature. Herein, we provide findings of a deeper analysis of these
three genes in the context to nasopharyngeal carcinoma (NPC) tumorigenesis. Their expression patterns were analyzed in a
more quantitative manner at transcript level. Their protein expression levels were also investigated. We showed results that
are contrary to previous report. Rather than downregulation, these genes were significantly overexpressed in NPC cell lines
compared to normal control at both transcript and protein levels. Nevertheless, their association with NPC has been established.
Immunoprecipitation pulldown assays indicate the plausible interaction of either RPeL27 or RPeL43 with POTEE/TUBA1A and
ACTB/ACTBL2 complexes. In addition, RPeL43 is shown to bind with MRAS and EIF2S1 proteins in a NPC cell line (HK1). Our
findings support RPeL27, RPeL41, and RPeL43 as potential markers of NPC and provide insights into the interaction targets of
RPeL27 and RPeL43 proteins.
1. Introduction
Ribosomal proteins (RPs) are primarily known for their
functions in ribosome biogenesis and play a central role
in translational processes. In fact, the highly coordinated
processes of ribosome biogenesis are also tightly connected
to events of cellular growth and development. Dysregulation
in these processes could relate to occurrence of diseases
that include cancers. It is also an established fact that the
phenotypic effects of RP genes extend beyond their canonical
ribosomal involvement into extraribosomal functions such as
DNA replication, transcription, DNA repair, DNA splicing
andmodification, and apoptosis [1]. In particular, differential
expression of ribosomal proteins (RPs) has also been related
to cancers [2, 3]. Recently all ribosomal protein genes have
been accorded new nomenclature [4], and this is used in this
paper we provide, but the old names are provided at their first
mention in the text.
Nasopharyngeal carcinoma (NPC), a malignancy arising
from epithelial cells of the nasopharynx, is a cancer that has
been extensively studied with respect to genetic susceptibility
and involvement. Early evidence of RP genes involvement
in NPC was limited to RPeS26 (RPS26), RPeS27 (RPS27),
RPuS19 (RPS15), RPeL27 (RPL27), RPeL43 (RPL37a), and
RPeL41 (RPL41) [5–7]. Albeit providing information on
NPC-associated RP genes, these preliminary findings are
largely speculative due to analysis that are semiquantita-
tive in nature and/or confined to assessment at transcript
level. Indeed, inconsistent results of RPeS26 and RPeS27 in
another study [8] nullified the verity of these two RP genes
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as NPC-associated factors. The case of RPuS19, although
identified from a large list of differential expressed genes
(via microarray assay) between NPC and noncancerous
nasopharyngeal tissue samples [6], was not subsequently
selected for validation via conventional or quantitative RT-
PCR analysis. Its upregulation in NPC samples was also
not evaluated at protein level. The three RP genes, RPeL27,
RPeL43, and RPeL41, were identified to be associated with
NPC from a study that employed semiquantitative RT-
PCR assay of all RP genes encoding products for the large
ribosome subunit [7]. Their underexpression in NPC cell
lines compared to normal epithelial cell line remains to be
reconfirmed using quantitative RT-PCR and/orWestern Blot
analysis. Without definitive results of expression pattern and
functional implications, the notion of NPC-associated RP
factors continues to be provisional and elusive.
Molecular pathways or signaling events pertaining to
carcinogenesis of NPC, hitherto, cannot categorically include
the involvement of RPs. Therefore, to establish RPs as among
the factors associated with NPC tumorigenesis, a reevalu-
ation of their expression patterns using more quantitative
assay is warranted. This paper reports the reanalysis of
expressed transcript level using quantitative RT-PCR strat-
egy of RPeL27, RPeL43, and RPeL41 in NPC cell lines in
comparison to normal cell line derived from noncancerous
nasopharyngeal epithelium. The upregulated trend of two of
these three genes was further substantiated at the protein
level, thus validating their association with NPC. Further
study on protein-protein interaction reveals plausible binding
of two of these three RPs with protein complexes of the cell
cytoskeleton, while one of the RPs was shown to possibly
interact with two types of oncoprotein.
2. Materials and Methods
2.1. Cell Culture. Nasopharyngeal carcinoma cell lines used
were SUNE1, HONE1, HK1, and TW01, and nonmalignant
nasopharyngeal epithelial cell line was NP69 [9]. Origi-
nal source and consent for use of these cell lines were
provided by Tsao et al., University of Hong Kong (Hong
Kong).TheNP69 cells were cultured in defined keratinocyte-
serum-freemedium (Invitrogen) supplemented with 5% fetal
bovine serum (Gibco), 100U/mL penicillin-streptomycin
(Gibco), and 0.2 ng/mL recombinant epidermal growth fac-
tor (Gibco), while SUNE1,HONE1,HK1, andTW01 cells were
grown in RPMI-1640 (Invitrogen) supplemented with 10%
FBS (Gibco) and 100U/mL penicillin-streptomycin (Gibco).
All cells were maintained at 37∘C with 5% carbon dioxide.
2.2. Quantitative Reverse Transcription-Polymerase Chain Re-
action (qRT-PCR). Total RNA was extracted with TRIzol
reagent (Invitrogen) according to the manufacturer’s pro-
tocol. First-strand cDNA was synthesized using QuantiTect
Reverse Transcription Kit (Qiagen) by standard method.
Real-time quantitative reverse transcription-PCR (qRT-PCR)
was performed in three technical replicates with two bio-
logical replicates using QuantiFast Probe (Qiagen) on a
Rotor-Gene 6000 Rotary Analyzer (Qiagen) and monitored
with Rotor-Gene 6000 software version 2.3.3 (Qiagen).
The primer-probe pairs used targeted RPeL27, RPeL41, and
RPeL43 genes. Beta actin (ACTB) was used as endogenous
control for gene expression normalization. Nontemplate
reactionswere included as negative controls.The fold changes
were calculated by using 2−ΔΔCt method.
2.3. Western Blotting. Whole cell protein lysates were pre-
pared using RIPA lysis buffer containing protease inhibitor
(Roche Applied Sciences). Proteins were separated on 12.5%
SDS-polyacrylamide gel electrophoresis and transferred onto
nitrocellulose membrane (Milipore). After blocking with
bovine serum albumin, the membranes were blotted with
the primary antibodies for RPeL27 or RPeL43 (Abcam),
followed by secondary anti-donkey, rabbit secondary anti-
body (Abcam). ACTB was used as protein loading control.
Analysis was not performed for RPeL41 due to lack of
commercially available primary antibody. Protein bands were
visualized using enhanced chemiluminescent (eCL) substrate
(Promega). Images were captured using ImageQuant TL
instrument (GE Healthcare) and band intensity was read
using ImageQuant TL software.
2.4. Immunoprecipitation PulldownAssay. Whole cell protein
lysate extracted from a NPC cell line (HK1) was incubated
with RPeL27 or RPeL43 primary antibody immobilized onto
Dynabeads Protein G (Life Technologies) for 10 minutes with
rotation at room temperature.The beads were vortexed for 30
seconds, and the vial was placed on DynaMag Magnet (Life
Technologies) to separate them from the solution. Following
removal of supernatant, sample buffer was added to the vial
and this mixture was boiled for 10 minutes. The resulting
immunoprecipitates were resolved on SDS-PAGE and stained
with Coomassie Blue (Bio-Rad). Protein bands of interest
were excised and sent to a service provider for protein
identification. Identification analysis was via the Electro-
spray Ionization-Quadrupole-Time-of-Flight (ESI-QUAD-
TOF) method using the Agilent 1260 Infinity HPLC system
coupled to Agilent 6540 mass spectrometer (Agilent) and the
Matrix Assisted Laser Desorption/Ionization Time-of-Flight
(MALDI-TOF) method using the 5800 Protein Analyzer (AB
Sciex). Identities of proteins were extracted using Mascot
software (Matrix Science) on Swiss-Prot database.The search
parameters utilized trypsin as the proteolytic enzyme with
one missed cleavage permitted and the carbamidomethyla-
tion of cysteines and oxidation of methionines as variable
modifications. Mass tolerance was 50 ppm and 0.4Da for
precursor and fragment ions, respectively.
3. Results
3.1. Overexpression of RPeL27, RPeL43, and RPeL41 in NPC
Cells. Based on our quantitative RT-qPCR results, all three
RP genes (RPeL27, RPeL43, andRPeL41) showoverexpression
in all NPC cell lines compared to normal nasopharyngeal
epithelial cells, while our Western Blot analysis reveals
upregulated protein level of RPeL27 and RPeL43 in NPC cell
lines relative to a normal control (Figure 1). Transcript levels
of RPeL27 in SUNE1 and HONE1 cell lines were 3.73- and
1.51-fold higher (𝑝 = 0.044 and 0.011) than in the normal
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Figure 1: RPeL27, RPeL43, and RPeL41 were overexpressed in transcript and protein level. (a) Bar graph with error bars of quantitative RT-
PCR assays measuring mRNA of all three RP genes in the five cell lines studied. ((b) and (c))Western blotting analysis results of protein levels
of RPeL27, RPeL43, and RPeL41 in five cell lines studied. Beta actin (ACTB) protein (Accession NM 001101 was used as reference and loading
control where values from RPs were normalized with).
nasopharyngeal epithelial cell line, NP69; andRPeL43mRNA
in SUNE1 and HONE1 cell lines was 2.23- (𝑝 = 0.009)
and 1.04-fold (𝑝 = 0.012) higher, respectively, compared to
NP69 (Figure 1(a)). This overexpression pattern is also seen
in RPeL41 with 2.74-fold in SUNE1 (𝑝 = 0.013) and 2.05-
fold in HONE1 (𝑝 = 0.028). However, the fold difference
of the three RP genes’ mRNA in HK1 and TW01 cell lines is
not statistically significant, albeit large differential expression
of all three RP genes between HK1 and NP69 cell lines
(Figure 1(a)). In terms of transcript level, RPeL27 shows the
highest expression in all NPC cell lines studied (Figure 1(a)).
Western Blot analysis shows upregulated protein levels of
RPeL27 and RPeL43 in the NPC cell lines of HONE1, HK1,
and TW01 compared to NP69 (Figures 1(b) and 1(c)). RPeL27
is 24.62 (𝑝 < 0.05), 13.05 (𝑝 < 0.01), and 27.67 (𝑝 < 0.05)
in HONE1, HK1, and TW01 cell lines, respectively, compared
to NP69 cell line. Meanwhile, RPL37a protein level was 3.71
and 7.76 (𝑝 < 0.05) in HONE1 and HK1 cell line, respectively.
In both protein and transcript levels, RPL27 showed overall
higher expression across the NPC cell lines compared to
RPL37a. ACTB (Accession NM 001101) was used as reference
gene and protein loading control to normalize the expression.
3.2. Proteins Interacting with RPeL27 and RPeL43. Based on
ESI-QUAD-TOFmass spectrum analysis, we identifiedMus-
cle Rat Sarcoma Homolog (MRAS) and Eukaryotic Initiation
Factor 2 Subunit 1 (EIF2S1) proteins as coimmunoprecipitates
of the RPeL43 protein (Table 1). The predicted size from ESI-
QUAD-TOF result matches the relative size of the protein
band in SDS-PAGE (25–35 kDa) (Figure 2(a)). Heavier pro-
teins in our SDS-PAGE assays that coimmunoprecipitate with
each of the RPeL27 and RPeL43 proteins (Figure 2(b)) were
later identified as POTE Ankyrin Family Member E- tubulin
alpha 1A (POTEE-TUBA1A) and beta actin-beta actin-like
4 Disease Markers
Table 1: Identification of proteins immunoprecipitated with RPeL27 or RPeL43 in NPC by ESI-QUAD-TOF MS. MW indicates molecular
weight. Accession number refers to SWISS-PROT protein database. Matches are the count of MS/MS spectra that have been matched to
peptides from this protein. Ion-score or peptide score is a probabilistic score indicating the goodness-of-fit between the observed MS/MS
spectrum and the theoretical spectrum of the proposed peptide. A higher score indicates a higher probability of a nonspurious match.
Significant threshold or 𝑝 value is used to determine statistical significance of matches between the observed and theoretical MS/MS spectra.
Sequence coverage is sequence of amino acids that has been inferred to be present based on mass spectral evidence.
Protein name MW (kDa) Accession number Matches Ion-score/𝑝 value Sequence coverage
EIF2S1 36089 P05198 10 31/18 16%
MRAS 23831 O14807 4 26/51 14%
EIF2S1
MRAS
RPeL27 IgGRPeL43
(a)
POTEE-TUBA1A
ACTB-ACTBL2
IgG RPeL43RPeL27
(b)
Figure 2: Protein-protein analysis using coimmunoprecipitation assay. (a) EIF2S1 andMRAS proteins were pulled down along with RPeL43.
(b) POTEE protein in complex with TUBA1A is the heavier protein complex that coimmunoprecipitates with both RPeL27 and RPeL43,
respectively, while the lighter complex was ACTB and ACTBL2 protein. IgG is negative control for coimmunoprecipitation assay where
antibody is not included to check for nonspecific binding of other proteins with protein G on beads.
2 (ACTB-ACTBL2) complexes via the MALDI-TOF analysis
(Table 2). Both RPeL27 and RPeL43 pulled down the same
complexes as they have similar weight in SDS-PAGE. Heavy
chain and light chain of the two primary antibodies RPeL27
and RPeL43 were detected but faint (not shown).
4. Discussion
Our results on the significantly upregulated levels of RPeL27,
RPeL43, and RPeL41 transcripts in NPC cell lines compared
to cultured normal NP cells warrant further discussion.
While this expression phenomenon reinforced the fact that
they are likely candidates of NPC-associated RP factors, their
expression behaviors contradict our previous report [7] of
downregulation in NPC cells. Such discrepancy is difficult to
explain, but, needless to say, our current findings are more
definitive due to the greater accuracy of quantitative RT-PCR
over semiquantitative strategy. Our current results also reveal
the upregulated trend of RPeL27 and RPeL43 protein levels in
NPC cells, thus substantiating and validating the outcomes of
transcript assessment. On this note, our previous report that
evaluated the end-point transcript level of these RP genes in
NPC scenario [7] will now have to be taken with caution.
The overexpression trends of these three RP genes are not
uncommon in cancers. For instance, RPeL27 is upregulated
in cells/tissues of sulforaphane treated-breast cancers [10],
gastric tubular adenoma and carcinoma [11], hepatocellular
carcinoma (HCC) [12], andmetastatic liver lesions [13], while
RPeL43 is upregulated in cases of astrocytomas [14], head
and neck squamous cell carcinoma [15, 16], and hepatitis
B-associated HCC [17]. The RPeL41 gene has been found to
be overexpressed in neoplastic lung fibroblast cells [18]. Our
findings are the first to show their overexpression in a variety
of cell lines derived from NPC tissues and subsequently
verified their status as plausible NPC-associated genetic
factors.
In terms of cell types, significantly higher transcript
level of the three RP genes is observed for cell lines
derived from the more common type of NPC tissues (Type
2a) comprising nonkeratinized poorly differentiated cells
(SUNE1 and HONE1). Despite prevailing overexpression,
statistical significance is not apparent in the case of cell
lines from well-differentiated NPC cells of either keratinized
(TW01) or nonkeratinized (HK1) characteristics. Protein
levels of RPeL27 are significantly higher in the three types
of cell lines, namely, the nonkeratinized poorly differentiated
(SUNE1/Type 2a-NPC), nonkeratinized well-differentiated
(HK1/Type 2b-NPC), and keratinized well-differentiated
(TW01/Type 1-NPC) cell types. Higher levels of RPeL43
proteins are statistically significant in all cell types except for
keratinized well-differentiated ones (TWO1). Taken together,
it is clear that this subset of RP genes is most consistently
overexpressed in cells from Type 2a-NPC tissues, hence
conferring them possible biomarkers for detection and/or
progression of this type of NPC. Our findings here provide
the first empirical evidence to support this conclusion.
Nevertheless, we have yet to further investigate all these
observations or prove these inferences in NPC tissues.
One of the proteins we found interacting with RPeL43 is
EIF2S1.This association is not a surprise bearing inmind that
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Table 2: Identification of proteins immunoprecipitated with RPeL27 or RPeL43 in NPC by ESI-QUAD-TOF MS. MW indicates molecular
weight. Accession number refers to SWISS-PROT protein database. Matches are the count of MS/MS spectra that have been matched to
peptides from this protein. Ion-score or peptide score is a probabilistic score indicating the goodness-of-fit between the observed MS/MS
spectrum and the theoretical spectrum of the proposed peptide. A higher score indicates a higher probability of a nonspurious match.
Significant threshold or 𝑝 value is used to determine statistical significance of matches between the observed and theoretical MS/MS spectra.
Sequence coverage is sequence of amino acids that has been inferred to be present based on mass spectral evidence.
Protein name MW (kDa) Accession number Matches Ion-score/𝑝 value Sequence coverage
POTEE 121286 Q6S8J3 2 94/<0.05 2%
TUBA1A 50104 F8VQQ4 2 33/<0.05 7%
ACTB 41710 P60709 3 73/<0.05 12%
ACTBL2 41976 Q562R1 2 50/<0.05 9%
EIF2S1 primarily functions as a translational initiation factor,
and its phosphorylation has been known to inhibit protein
synthesis [19]. In leukemia cells, the phosphorylation of
EIF2S1 also inhibits the activities of nicotinamide phosphori-
bosyltransferase (NAMPT), a factor known to regulate cancer
cell metabolism [20]. Exactly how the interaction among
RPeL43, EIF2S1, and NAMPT attributes to dysfunctional or
normal growth and proliferation of nasopharyngeal epithelial
cells is unclear and can only be elucidated via further
functional studies. However, our limited findings here do
suggest a probable role of RPeL43 in cell growth regulation
when in complex with EIF2S1.
Another protein identified to be in complex with RPeL43
is MRAS. As activator of other protooncogenes such as
Rapidly Accelerated Fibrosarcoma (RAF) kinases [21], Phos-
phoinositide-3-Kinase (P13K) [22], Afadin (AF6) [23], and
Guanine Nucleotide Exchange Factors (GEFs) [24], MRAS
also triggers Mitogen-Activated Protein Kinases/Extracellu-
lar Signal-Regulated Kinases- (MAPK/ERK-) independent
gene expression in breast cancer cells [25]. Our studies are
the first to identify possible association between an RP and
the MRAS protein in the NPC context. Other Ras family
members previously implied in NPC-related tumorigenesis
are V-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog
(KRAS) and Transforming Protein p21 (HRAS) [26].
For the heavier molecules (POTEE-TUBA1A and ACTB-
ACTBL2 complexes) that coimmunoprecipitated with
RPeL27 or RPeL43, precise mode of interaction (one-to-one
binding) cannot be discerned via our analysis. Each RP’s
interaction with either one of the complexes could be due to
protein aggregation in the assay or actual tertiary structures
in the natural state. Under normal circumstances, POTEE (or
POTE-2𝛾) colocalizes with actin beneath the cell membrane
[27] but has been known to translocate from cytoplasm
to nucleoli in response to conditions of malignancy [28].
Whether and how RPeL27 or RPeL43 is involved in this event
during NPC tumorigenesis remains to be studied. Despite
expression in normal tissues of the prostate, ovary, testis, and
placenta (hence the acronym POTE), transcripts of POTEE
gene are also detected in tissues of prostate, breast, lung,
colon, and ovarian cancers [29]. In the current study, we
reveal the presence of POTEE proteins in NPC cells, albeit
in association with RPeL27-TUBA1A or RPeL43-TUBA1A
complexes. Among the tubulin superfamily, only beta-
tubulin family member, specifically the beta 2-tubulin chain
(TBB2), is possibly associated with NPC in that its protein
level is downregulated in an Epstein-Barr virus-associated
NPC cell line (C666-1) [30]. On the other hand, none of
the alpha-tubulin family members has been linked to NPC
before this study, despite their association with prostate
cancer [31] and neuroblastoma [32]. The tubulin alpha-1A
(TUBA1A) has only been linked to non-small cell lung
carcinomas [33]. Our findings herein are the first to suggest
its involvement in NPC tumorigenesis albeit of mechanism
yet to be discovered.
In the case of RPeL27-ACTB-ACTBL2 or RPeL43-ACTB-
ACTBL2 complexes, little is known about the roles of either
complex in NPC or any other cancer situations. Indeed, the
association of ACTB with a wide range of cancer types (liver,
renal, colorectal, gastric, pancreatic, esophageal, lung, breast,
prostate, and ovarian cancers and leukemia, melanoma, and
lymphoma) has been explained [34] and that of ACTBL2
in some hepatocellular carcinoma has been reported [35].
However, the combined effects of ACTB, ACTBL2, and either
RPeL27 or RPeL43 in malignant transformation of human
cells are unclear. Taking together the findings from our co-
IP assays, we could perhaps suspect an RPeL27- and RPeL43-
aided involvement of theMAPK/ERKpathway inmalignancy
of the nasopharynx since factors such asMRAS andmembers
of actin and tubulin families have been identified.This hunch
can be among the bases for deeper studies into RP-mediated
mechanism in molecular pathogenesis of NPC.
5. Conclusion
This study verified RPeL27, RPeL41, and RPeL43 as NPC-
associated ribosomal protein genes as far as cell line system
is concerned. We provide preliminary knowledge on the
development of novel markers for early diagnosis and/or
prognosis of the nasopharyngeal cancer disease. In addition,
we provide early evidence suggesting possible roles of RPeL27
and RPeL43 in the MAPK/ERK pathway.
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